| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 10, 2025 | Oct 14, 2025 | Akero Therapeutics, Inc. | CEO | Sell | 27.5 | -30,000 | -5.39% | ✓ | $1.6M |
| Sep 10, 2025 | Sep 12, 2025 | Akero Therapeutics, Inc. | CEO | Sell | 27.5 | -31,796 | -6.29% | ✓ | $1.4M |
| Aug 11, 2025 | Aug 13, 2025 | Akero Therapeutics, Inc. | CEO | Sell | 27.5 | -30,000 | -5.76% | ✓ | $1.5M |
| Jul 10, 2025 | Jul 11, 2025 | Akero Therapeutics, Inc. | CEO | Sell | 27.5 | -30,000 | -5.45% | ✓ | $1.5M |
| Jun 18, 2025 | Jun 20, 2025 | Akero Therapeutics, Inc. | CEO | Sell | 40.0 | -6,620 | -1.19% | ✗ | $363K |
| Jun 10, 2025 | Jun 12, 2025 | Akero Therapeutics, Inc. | CEO | Sell | 27.5 | -37,837 | -6.37% | ✓ | $2M |
| May 12, 2025 | May 13, 2025 | Akero Therapeutics, Inc. | CEO | Sell | 32.5 | -30,000 | -4.81% | ✓ | $1.2M |
| Apr 10, 2025 | Apr 11, 2025 | Akero Therapeutics, Inc. | CEO | Sell | 32.5 | -30,000 | -4.58% | ✓ | $1.1M |
| Mar 12, 2025 | Mar 14, 2025 | Akero Therapeutics, Inc. | CEO | Sell | 47.5 | -1,738 | -0.26% | ✗ | $78K |
| Mar 10, 2025 | Mar 12, 2025 | Akero Therapeutics, Inc. | CEO | Sell | 32.5 | -30,000 | -4.37% | ✓ | $1.3M |
| Feb 10, 2025 | Feb 11, 2025 | Akero Therapeutics, Inc. | CEO | Sell | 32.5 | -30,000 | -4.19% | ✓ | $1.6M |
| Jan 27, 2025 | Jan 29, 2025 | Akero Therapeutics, Inc. | CEO | Sell | 32.5 | -30,000 | -4.02% | ✓ | $1.6M |
| Dec 10, 2024 | Dec 12, 2024 | Akero Therapeutics, Inc. | CEO | Sell | 42.5 | -7,855 | -1.30% | ✗ | $241.9K |
| Dec 2, 2024 | Dec 4, 2024 | Akero Therapeutics, Inc. | CEO | Sell | 35.0 | -25,000 | -3.97% | ✓ | $802.3K |
| Nov 1, 2024 | Nov 5, 2024 | Akero Therapeutics, Inc. | CEO | Sell | 23.8 | -108,366 | -8.21% | ✓ | $3.4M |
| Oct 16, 2024 | Oct 18, 2024 | Akero Therapeutics, Inc. | CEO | Sell | 32.5 | -91,634 | -3.65% | ✓ | $2.9M |
| Sep 10, 2024 | Sep 13, 2024 | Akero Therapeutics, Inc. | CEO | Sell | 51.3 | -1,738 | -0.29% | ✗ | $45.5K |
| Jun 11, 2024 | Jun 13, 2024 | Akero Therapeutics, Inc. | CEO | Sell | 42.5 | -7,894 | -1.34% | ✗ | $178.7K |
| Mar 13, 2024 | Mar 15, 2024 | Akero Therapeutics, Inc. | CEO | Sell | 47.5 | -1,969 | -0.33% | ✗ | $55.8K |
| Mar 4, 2024 | Mar 6, 2024 | Akero Therapeutics, Inc. | CEO | Sell | 20.0 | -75,000 | -11.25% | ✓ | $2.5M |
| Dec 14, 2023 | Dec 18, 2023 | Akero Therapeutics, Inc. | CEO | Sell | 51.3 | -1,628 | -0.29% | ✗ | $33.8K |
| Dec 7, 2023 | Dec 11, 2023 | Akero Therapeutics, Inc. | CEO | Sell | 90.0 | +64,563 | 3.29% | ✓ | $540K |
| Oct 2, 2023 | Oct 4, 2023 | Akero Therapeutics, Inc. | CEO | Sell | 27.5 | -25,000 | -5.14% | ✓ | $1.2M |
| Sep 13, 2023 | Sep 25, 2023 | Akero Therapeutics, Inc. | CEO | Sell | 48.8 | -1,682 | -0.36% | ✓ | $84.7K |
| Sep 1, 2023 | Sep 18, 2023 | Akero Therapeutics, Inc. | CEO | Sell | 27.5 | -25,000 | -5.13% | ✓ | $1.2M |
| Aug 1, 2023 | Aug 3, 2023 | Akero Therapeutics, Inc. | CEO | Sell | 27.5 | -25,000 | -5.29% | ✓ | $1.1M |
| Jul 3, 2023 | Jul 6, 2023 | Akero Therapeutics, Inc. | CEO | Sell | 27.5 | -25,000 | -5.29% | ✓ | $1.1M |
| Jun 13, 2023 | Jun 15, 2023 | Akero Therapeutics, Inc. | CEO | Sell | 48.8 | -1,613 | -0.39% | ✓ | $89K |
| Jun 1, 2023 | Jun 5, 2023 | Akero Therapeutics, Inc. | CEO | Sell | 27.5 | -25,000 | -5.76% | ✓ | $1.1M |
| Apr 18, 2023 | May 3, 2023 | Akero Therapeutics, Inc. | CEO | Sell | 27.5 | -25,000 | -5.76% | ✓ | $1.1M |
| Apr 3, 2023 | Apr 5, 2023 | Akero Therapeutics, Inc. | CEO | Sell | 30.0 | -25,000 | -6.34% | ✓ | $948.6K |
| Mar 10, 2023 | Mar 14, 2023 | Akero Therapeutics, Inc. | CEO | Sell | 47.5 | -1,706 | -0.46% | ✗ | $74.2K |
| Mar 1, 2023 | Mar 3, 2023 | Akero Therapeutics, Inc. | CEO | Sell | 27.5 | -25,000 | -6.31% | ✓ | $1.2M |
| Feb 1, 2023 | Feb 3, 2023 | Akero Therapeutics, Inc. | CEO | Sell | 27.5 | -25,000 | -6.31% | ✓ | $1.2M |
| Jan 3, 2023 | Jan 5, 2023 | Akero Therapeutics, Inc. | CEO | Sell | 27.5 | -25,000 | -6.31% | ✓ | $1.3M |
| Dec 1, 2022 | Dec 2, 2022 | Akero Therapeutics, Inc. | CEO | Sell | 35.0 | -10,000 | -3.12% | ✓ | $460.7K |
| Nov 1, 2022 | Nov 2, 2022 | Akero Therapeutics, Inc. | CEO | Sell | 35.0 | -10,000 | -3.12% | ✓ | $434.2K |
| Oct 3, 2022 | Oct 5, 2022 | Akero Therapeutics, Inc. | CEO | Sell | 35.0 | -10,000 | -3.12% | ✓ | $332.3K |
| Sep 13, 2022 | Sep 15, 2022 | Akero Therapeutics, Inc. | CEO | Sell | 15.0 | -60,000 | -16.21% | ✓ | $1.6M |
| Mar 1, 2022 | Mar 2, 2022 | Akero Therapeutics, Inc. | CEO | Sell | 37.5 | -10,000 | -3.13% | ✓ | $175.9K |
| Feb 1, 2022 | Feb 3, 2022 | Akero Therapeutics, Inc. | CEO | Sell | 37.5 | -10,000 | -3.13% | ✓ | $175.6K |
| Jan 10, 2022 | Jan 11, 2022 | Akero Therapeutics, Inc. | CEO | Sell | 37.5 | -10,000 | -3.24% | ✓ | $195.5K |
| Dec 2, 2021 | Dec 3, 2021 | Akero Therapeutics, Inc. | CEO | Sell | 30.0 | -17,500 | -6.40% | ✓ | $353.2K |
| Nov 2, 2021 | Nov 3, 2021 | Akero Therapeutics, Inc. | CEO | Sell | 30.0 | -17,500 | -6.01% | ✓ | $395K |
| Oct 4, 2021 | Oct 5, 2021 | Akero Therapeutics, Inc. | CEO | Sell | 30.0 | -17,500 | -5.67% | ✓ | $377K |
| Sep 2, 2021 | Sep 3, 2021 | Akero Therapeutics, Inc. | CEO | Sell | 30.0 | -17,500 | -5.37% | ✓ | $418.1K |
| Aug 3, 2021 | Aug 4, 2021 | Akero Therapeutics, Inc. | CEO | Sell | 30.0 | -17,500 | -5.09% | ✓ | $364.6K |
| Jul 2, 2021 | Jul 6, 2021 | Akero Therapeutics, Inc. | CEO | Sell | 35.0 | -17,500 | -4.86% | ✓ | $433.7K |